Stock Comparison
TAK vs TEVA
Takeda Pharmaceutical Co Ltd ADR and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$50.27B
$38.67B
P/E (TTM)
—
24.8
Forward P/E
10.3
16.0
Price/Sales
0.0
2.2
Price/Book
1.1
4.7
EV/EBITDA
16.9
16.3
Dividend Yield
4.16%
—
Profitability
Net Margin
-3.38%
9.02%
Operating Margin
11.10%
19.20%
Return on Equity
-2.12%
21.60%
Return on Assets
2.55%
6.38%
Growth (YoY)
Revenue Growth
3.90%
2.30%
Earnings Growth
330.20%
72.20%
Price & Risk
Beta
0.1
0.9
52-Week High
$18.90
$37.35
52-Week Low
$12.78
$14.99
Analyst Target
$20.60
$40.90
Compare TAK and TEVA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.